1. Home
  2. ICUI vs NOMD Comparison

ICUI vs NOMD Comparison

Compare ICUI & NOMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • NOMD
  • Stock Information
  • Founded
  • ICUI 1984
  • NOMD 2014
  • Country
  • ICUI United States
  • NOMD United Kingdom
  • Employees
  • ICUI N/A
  • NOMD N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • NOMD Packaged Foods
  • Sector
  • ICUI Health Care
  • NOMD Consumer Staples
  • Exchange
  • ICUI Nasdaq
  • NOMD Nasdaq
  • Market Cap
  • ICUI 3.3B
  • NOMD 2.6B
  • IPO Year
  • ICUI 1992
  • NOMD N/A
  • Fundamental
  • Price
  • ICUI $119.25
  • NOMD $12.63
  • Analyst Decision
  • ICUI Buy
  • NOMD Strong Buy
  • Analyst Count
  • ICUI 6
  • NOMD 5
  • Target Price
  • ICUI $186.60
  • NOMD $20.40
  • AVG Volume (30 Days)
  • ICUI 285.2K
  • NOMD 1.9M
  • Earning Date
  • ICUI 11-11-2025
  • NOMD 11-13-2025
  • Dividend Yield
  • ICUI N/A
  • NOMD 5.36%
  • EPS Growth
  • ICUI N/A
  • NOMD 6.08
  • EPS
  • ICUI N/A
  • NOMD 1.57
  • Revenue
  • ICUI $2,372,504,000.00
  • NOMD $3,605,402,231.00
  • Revenue This Year
  • ICUI N/A
  • NOMD $1.01
  • Revenue Next Year
  • ICUI N/A
  • NOMD $2.04
  • P/E Ratio
  • ICUI N/A
  • NOMD $8.15
  • Revenue Growth
  • ICUI 2.96
  • NOMD 0.29
  • 52 Week Low
  • ICUI $107.00
  • NOMD $12.58
  • 52 Week High
  • ICUI $196.26
  • NOMD $20.81
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 42.14
  • NOMD 27.76
  • Support Level
  • ICUI $117.69
  • NOMD $12.58
  • Resistance Level
  • ICUI $125.00
  • NOMD $13.36
  • Average True Range (ATR)
  • ICUI 4.04
  • NOMD 0.32
  • MACD
  • ICUI -0.69
  • NOMD 0.02
  • Stochastic Oscillator
  • ICUI 23.20
  • NOMD 3.70

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About NOMD Nomad Foods Limited

Nomad Foods Ltd is a packaged foods company that is involved in the business of manufacturing and distribution of branded frozen foods in Western Europe. The company manufactures and markets frozen food products such as fish, vegetables, poultry, Ice Cream and ready meals like pizza. It sells its products through large grocery retailers under the brand Birds Eye in the United Kingdom and Ireland, Findus in Italy, France, Spain, and Scandinavia, and Iglo in Germany and other continental markets. The company operates through a single segment being Frozen. The majority of the revenue is generated from the United Kingdom.

Share on Social Networks: